Cancer Gene Therapy : Impact Factor & More
eISSN: 1476-5500pISSN: 0929-1903
Share this on:
Key Metrics
CiteScore 
8.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Cancer Research
SNIP
0.97
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Gene Therapy
Cancer Gene Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Gene Therapy
M6A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-β/SMAD signaling in cervical cancer.
- 3 Jan 2026
- Cancer gene therapy
The role of hsa_circ_0000520 in breast cancer progression: insights into the miR-542-3p/TMBIM6 regulatory axis.
- 18 Dec 2025
- Cancer gene therapy
NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis.
- 12 Dec 2025
- Cancer gene therapy
Pleiotropic effects of all-trans retinoic acid in attenuating the hallmarks of colorectal cancer- challenges and scope of differentiation therapy.
- 10 Dec 2025
- Cancer gene therapy
The legacy of a humble scientist: Edoardo Alesse, MD, PhD (1958-2025).
- 7 Dec 2025
- Cancer gene therapy
PRDX1 depletion predisposes to ferroptosis through inhibiting the cAMP pathway in B-cell acute lymphoblastic leukemia.
- 5 Dec 2025
- Cancer gene therapy
M6A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-β/SMAD signaling in cervical cancer.
- 3 Jan 2026
- Cancer gene therapy
The role of hsa_circ_0000520 in breast cancer progression: insights into the miR-542-3p/TMBIM6 regulatory axis.
- 18 Dec 2025
- Cancer gene therapy
NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis.
- 12 Dec 2025
- Cancer gene therapy
Pleiotropic effects of all-trans retinoic acid in attenuating the hallmarks of colorectal cancer- challenges and scope of differentiation therapy.
- 10 Dec 2025
- Cancer gene therapy
The legacy of a humble scientist: Edoardo Alesse, MD, PhD (1958-2025).
- 7 Dec 2025
- Cancer gene therapy
PRDX1 depletion predisposes to ferroptosis through inhibiting the cAMP pathway in B-cell acute lymphoblastic leukemia.
- 5 Dec 2025
- Cancer gene therapy
FAQs on Cancer Gene Therapy
How long has Cancer Gene Therapy been actively publishing? 
What is the publishing frequency of Cancer Gene Therapy?
How many articles did Cancer Gene Therapy publish last year?
What is the eISSN & pISSN for Cancer Gene Therapy?
What is Citescore for Cancer Gene Therapy?
What is SNIP score for Cancer Gene Therapy?
What is the SJR for Cancer Gene Therapy?
Who is the publisher of Cancer Gene Therapy?
